Tofacitinib Efficacy and Safety in Patients with Ankylosing Spondylitis by Baseline C-Reactive Protein Levels: A Post Hoc Analysis

被引：0
|
作者：
Deodhar, Atul [1 ]
Baraliakos, Xenofon [2 ]
Magrey, Marina Nighat [3 ]
Gensler, Lianne [4 ]
Thorat, Amit V. [5 ]
Pemmaraju, Surya [6 ]
Cadatal, Mary Jane [7 ]
Nash, Peter [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR USA
[2] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Herne, Germany
[3] Case Western Reserve Univ, Univ Hosp, Cleveland, OH USA
[4] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA USA
[5] Pfizer Australia, Sydney, Australia
[6] Pfizer Inc, Chennai, Tamil Nadu, India
[7] Pfizer Inc, Manila, Philippines
[8] Griffith Univ, Sch Med, Brisbane, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0518
引用
收藏
页码：1012 / 1014
页数：3
相关论文
共 50 条
  • [1] TOFACITINIB EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS BY BASELINE C-REACTIVE PROTEIN LEVELS: A POST HOC ANALYSIS
    Deodhar, A.
    Baraliakos, X.
    Magrey, M.
    Gensler, L. S.
    Thorat, A. V.
    Kinch, C.
    Pemmaraju, S.
    Cadatal, M. J.
    Nash, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1685 - 1686
  • [2] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials
    Deodhar, Atul
    Baraliakos, Xenofon
    Magrey, Marina
    Gensler, Lianne S.
    Thorat, Amit, V
    Pemmaraju, Surya Kiran
    Cadatal, Mary Jane
    Nash, Peter
    [J]. JOURNAL OF RHEUMATOLOGY, 2024, 51 (08) : 772 - 780
  • [3] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
    Norton, Hillary
    Sliwinska-Stanczyk, Paula
    Hala, Tomas
    Elzorkany, Bassel
    Stockert, Lori
    Shi, Harry
    Wang, Cunshan
    Paulissen, Jerome
    Ritchlin, Christopher
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803
  • [4] Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease-Modifying Antirheumatic Drug Use: A Post Hoc Analysis
    Deodhar, Atul
    Marzo-Ortega, Helena
    Wu, Joseph
    Wang, Cunshan
    Dina, Oluwaseyi
    Kanik, Keith S.
    Fallon, Lara
    Gensler, Lianne S.
    [J]. ACR OPEN RHEUMATOLOGY, 2023, 5 (12) : 632 - 643
  • [5] C-Reactive Protein Levels in Patients with or without Structural Progression: A Post-Hoc Analysis from a Phase 3 Tofacitinib Trial
    Fleischmann, Roy
    Connell, Carol A.
    Fan, Haiyun
    Strengholt, Sander
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] EFFICACY OF TOFACITINIB IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS BY BASELINE C-REACTIVE PROTEIN LEVELS AND ERYTHROCYTE SEDIMENTATION RATES
    Schwartzman, S.
    van Vollenhoven, R.
    Matsumoto, A.
    Orange, D.
    Shah, S.
    DeMasi, R.
    Fan, H.
    Dahl, P.
    Wouters, A.
    Keystone, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 918 - 918
  • [7] Efficacy of Tofacitinib in Patients with Moderate to Severe Rheumatoid Arthritis By Baseline C-Reactive Protein Levels and Erythrocyte Sedimentation Rates
    Schwartzman, Sergio
    van Vollenhoven, Ronald F.
    Matsumoto, Alan K.
    Orange, Dana
    Shah, Shweta
    DeMasi, Ryan
    Fan, Haiyun
    Dahl, Palle
    Wouters, Ann
    Keystone, Edward C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [8] SECUKINUMAB DEMONSTRATES RAPID AND SUSTAINED EFFICACY IN ANKYLOSING SPONDYLITIS PATIENTS WITH NORMAL OR ELEVATED BASELINE C-REACTIVE PROTEIN LEVELS: POOLED ANALYSIS OF TWO PHASE 3 STUDIES
    Barkham, Nick
    Braun, Juergen
    Sieper, Joachim
    Landewe, Robert
    Baraliakos, Xenofon
    Miceli-Richard, Corinne
    Quebe-Fehling, Erhard
    Porter, Brian
    Gandhi, Kunal
    van der Heijde, Desiree
    [J]. RHEUMATOLOGY, 2019, 58 : 153 - 154
  • [9] C-REACTIVE PROTEIN AS A PREDICTOR OF TREATMENT RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Baraliakos, X.
    Szumski, A.
    Koenig, A.
    Jones, H.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 787 - 787
  • [10] The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis
    Baraliakos, Xenofon
    Szumski, Annette
    Koenig, Andrew S.
    Jones, Heather
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 997 - 1004
12345